Abbott slumps after reporting sales miss, disappointing Q1 guidance
Abbott Laboratories fell in premarket trading after it reported fourth-quarter sales that missed Wall Street estimates and gave disappointing guidance for the current quarter.
The company said it expects to report first-quarter adjusted earnings per share of between $1.12 and $1.18, below the $1.20 analysts polled by FactSet were expecting. For the full year, it expects to report adjusted earnings per share of $5.55 to $5.80, in line with the $5.67 the Street is penciling in.
Abbott also reported $11.5 billion in sales for the fourth quarter, less than the analyst consensus of $11.8 billion. The sales miss was driven by lower-than-expected sales of its medical devices, its largest segment. Its profits for the quarter hit $1.50 per share, right in line with expectations.
The stock fell more than 5% in premarket trading on Thursday.